|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0086 USD | 0.00% |
|
0.00% | -95.41% |
| 05/03 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
| 16/02 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
Peak Bio, Inc. announced that it has entered into a securities purchase agreement to issue senior secured promissory note for gross proceeds of $75,000 on January 23, 2024. The transaction included participation from individual lender Huh. The promissory note carry a interest rate of 15% per annum.
The note will mature on January 23, 2025. The company will seek additional bridge loans of up to an additional $4,250,000.
| 1st Jan change | Capi. | |
|---|---|---|
| -95.41% | 199K | |
| +49.52% | 56.69B | |
| -3.05% | 41B | |
| +38.14% | 38.11B | |
| -11.22% | 26.89B | |
| +14.89% | 25.59B | |
| -22.61% | 18.59B | |
| +0.10% | 12.39B | |
| +26.60% | 11.99B | |
| +22.35% | 11.88B |
PEAK BIO, INC. 
